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INTRODUCTION
In the last 15 years, the search for anti-tumour drugs has been largely shifted from direct targeting of the cell replicative mechanism to the overexpressed molecules to which is attributed the responsibility for the tumour malignancy [1] . Similarly, the research for new chemical entities has been oriented to match with this new fashion with a series of novel compounds to which it has often been attributed the adjective of "biological" drugs because of their similitude with endogenous compounds [2] . This strategy of anti-tumour chemotherapy has produced monoclonal antibodies against receptors overexpressed by cancer cells and small molecules, mainly, but not only, inhibitors of tyrosine kinases representing the pathways responsible for the malignancy of the tumour cells [3] [4] [5] . This new approach accounts for certain improvements of the anticancer chemotherapy [6] , but the initial enthusiasm has been reduced because of the onset of tumour resistance and because of the tumour cell heterogeneity with often only few cells in a tumour that have responded to therapy [7] [8] [9] [10] .
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4 the hypothesis that also the activity of platinum drugs may depend on the characteristic pathways of the tumour cells, and in this way it can be explained the relative sensitivity of certain tumours [15] [16] [17] [18] [19] [20] [21] . However, tumour growth in the primary and metastatic sites depends also from the relationships that cancer cells hire with the healthy cells surrounding the tumour mass. The presence of a number of healthy cells in the tumour mass is believed to help the growth of the tumour [22, 23] , and is suspected it can interfere with the activity of the anti-tumour drugs [24] [25] [26] [27] . This interference may be even greater with the "targeted drugs" for which any external influence on the expression/activity of the pathways of malignancy may represent an obstacle to their efficacy.
Among the metal-based drugs, the imidazolium trans-imidazoledimethylsulphoxidetetrachloro ruthenate (NAMI-A) has shown important differences of the mechanism of anti-tumour action. It shows only poor capacity to bind to DNA [28] , also because of its poor ability to get into the cells [29] while causing a pronounced reduction of the metastatic capacity of the tumours [30] [31] [32] . The selectivity of NAMI-A for the tumour metastases has been attributed to its ability to control the angiogenic potential of the tumour [33, 34] , and to control the integrin-dependent interaction of the tumour with its growth microenvironment [35] [36] [37] .
With the present investigation we have studied the capacity of the healthy cells surrounding the colorectal cancer cells, in the primary site or in the liver metastases, to influence the effects of NAMI-A on the tumour cells themselves. The study has been therefore carried out with co-cultures mimicking the primary site of tumour growth (co-culture between the HCEC epithelial cells and the HCT-116 colorectal
cancer cells) and of the liver metastatic site (co-culture between the IHH hepatocytes and the HCT-116 colorectal cancer cells). At the end, the medium containing the ruthenium compound was removed, the cells carefully washed with PBS, and 100 l of fresh PBS added to each well. using SsoAdvanced SYBR Green Supermix (Bio-Rad) following manufacturer's protocol. The following thermal profile was used: an initial 30 sec denaturation step at 95°C, followed by 40 cycles at 95°C for 15 sec and at 55°C for 30 sec. Amplification products were analysed using a 65°C/95°C melting curve. The MIT Prime3 online protocol was used to design the primer sequences reported in Table 1 . Primers were designed to avoid the non-specific amplification of other human transcripts by an in silico analysis via BLASTn against the annotated human genome (Ensambl release 68) [38] . Primer specificity was further assessed by a melting curve analysis of RT-PCR products. Primers were purchased from Invitrogen. Gene expression levels were calculated using the comparative Ct method and normalized using the RPL5 gene as the internal control [39] . The results are provided as the mean and standard deviation of three technical replicates. 
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WOUND HEALING ASSAY
The assay was conducted according to the protocol described by Liang et al. [40] .
Briefly, HCT-116 cells were sown in complete medium in 24-well plates (4x10 Cells were then incubated for 48 h at 37°C and 5% CO 2 . Treatment solutions were removed and cells fixed with 1.1% glutaraldeyde for 15 min. After a careful wash the plates were air-died and cells observed at light microscopy equipped with a Leica DC300 acquisition system.
TARGETED SECRETOME ANALYSIS OF THE IHH-CM PROFILING BY MULTIPLEXED IMMUNOASSAY
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The targeted quantitative analysis of secreted cytokines and chemokines in IHH-CM was performed by using the Bio-Plex multiplex system (Bio- (La Jolla, CA USA). Expression data were also imported into the excel software for further analyses.
STATISTICAL ANALYSIS
Results are processed using InstatGraph3 software and presented as mean  S.D..
The group means are compared using a two-Way Analysis of Variance (ANOVA)
followed by t-test, or Tukey-Kramer post-test and are considered significant when p<0.05. 
THE COMPOSITION OF THE IHH SECRETOME
To investigate the profile of cytokines and growth factors secreted by the IHH hepatocytes, a multiplexed immunoassay-based platform was used. Unconditioned media were in parallel analysed as a reference sample for comparative purposes.
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We found that several soluble factors, including both pro-inflammatory and antiinflammatory cytokines, chemokines and growth factors, are highly enriched in the IHH conditioned media (Table 2 ). In particular, we focused our attention on the MCP-1 chemokine and the VEGF growth factor for which the highest concentrations are measured (700 and 1600 pg/ml, respectively). 
NAMI-A CURBS THE MIGRATION OF HCT-116 CELLS
DISCUSSION
The new innovative approaches to cancer chemotherapy, besides the direct targeting of the cancer cell, take into consideration also the tumour microenvironment where the neoplasm is growing [26, 41] . This new view implies a role for the microenvironment for either the growth of the tumour and for the response of the tumour cells to the anticancer therapies [23, 25, 27, 42] . In short, it might be said that tumour cells recruit host cells and soluble factors to help themselves to grow and to be protected against chemicals used for their destruction. Then, it is not surprising that many targeted therapies are only marginally effective or rapidly become ineffective even when they are expected to be highly cytotoxic to cancer cells because of the selective targeting of a pathway crucial to cell survival [24, 43, 44] .
Recent evidences with the platinum drugs suggest that also the metal-based chemicals are sensitive to the microenvironment of tumour growth [45, 46] . Platinum and VEGF. Both these factors are known to be involved in cancer growth and dissemination [53] [54] [55] . Accordingly, we found that both the single and simultaneous [63, 64] . In these studies, the tumour cells 
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